Profile
Dawn Pinchasik is currently Vice President-Clinical Development at TScan Therapeutics, Inc. since 2024.
Education includes a graduate degree from the University of Cincinnati (Ohio) and a doctorate from Drexel University College of Medicine.
Dawn Pinchasik active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/02/2024 |
Training of Dawn Pinchasik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Cincinnati (Ohio)
University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
- Stock Market
- Insiders
- Dawn Pinchasik
















